RXST insider trading
HealthcareRxSight, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About RxSight, Inc.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Company website: www.rxsight.com
RXST insider activity at a glance
FilingIQ has scored 322 insider transactions for RXST since Jul 30, 2021. The most recent filing in our index is dated Apr 17, 2026.
Across the full history, 28 open-market purchases
and 125 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RXST insider trades is 51.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RXST Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for RXST?
- FilingIQ tracks 322 Form 4 insider transactions for RXST (RxSight, Inc.), covering filings from Jul 30, 2021 onwards. 16 of those were filed in the last 90 days.
- Are RXST insiders net buyers or net sellers?
- Across the full Form 4 history for RXST, 28 transactions (9%) were open-market purchases and 125 (39%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RXST insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is RXST in?
- RxSight, Inc. (RXST) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $346.33M.
Methodology & sources
Every RXST insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.